1MELIAW M, JOHNSON P J, WILLIAM S R, et al. Induction of remission in hepatocellular carcinoma: a comparison of etopo side (VP-16) with adriamycin[J]. Cancer,1983,51:206.
2SHIU W C T. Primary liver cancer in Hongkong[J]. Cancer Chemother Pharmacol,1992,31(Suppl 1) :s143.
3PORTAC, MORONI M, NASTASI G, et al. 5-fluorouracil and leucovoricaleiumare active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase study[J].Oncology,1995,52:487.
4KHOO K S, AU E, KOO W H, et al. Phasell study of NSC 620212-doxorubicin HCL liposome injection (lipodox) in hepatocellular carcinoma (HCC)[abstract][J].Pro Am Soc Clin Oncol, 1996,15:226.
5Atkin WS, et al. Long- term risk of colorectal cacer after excision of rectosigmold adenomas. N Engl J Med, 1992 ;326:653--662.
6Bedenne L, et al. Adenoma - carcinoma sequence of "de nove" carcinogenesis? Cancer, 1992 ; 69: 883 - 888.
7Jass JR,Sobin LH. Histological typing of intestinal tumors. In:WHO international histological clsaaification of tumors. Berlin: Springer Verlag, 1989 : 29-31.
8E Thiis- Evensen ,et al. Flexible sigmoidescopy or colonoscopy as a screening modality for colorecal adenornas in oler age groups? Findings in a cohort of the nomrmal population aged 63-72 years. Gut,1999 ; 45 : 834 -839.
9Kairasp C,et al. Adenoma size and number anr predictive of adenoma recurence implications for surveillance colonoscopy. Gastrointest Endosc,2000; 51:433-437.
10Euscher ED , et al. Large colorectal adenorrms. An approach to pathologic evalation. Am J Clin Pathol,2001 ; 116: 336-340.
